MODELING THE IMPACT OF THE VACCINE CANDIDATE TAK-003 ON THE INCIDENCE OF DENGUE IN FRENCH OVERSEAS TERRITORIES

被引：0
|
作者：
Nucit, A. [1 ]
Moreau, R. [2 ]
Massetti, M. [2 ]
Strub, C. [3 ]
Kharitonova, E. [4 ]
Tytula, A. [5 ]
Zawieja, J. [5 ]
Leleu, H. [2 ]
Shen, J. [6 ]
机构：
[1] Takeda France SAS, F-75 Paris, France
[2] Publ Hlth Expertise, F-75 Paris, France
[3] Takeda France SAS, Paris, France
[4] Putnam PHMR, Paris, France
[5] Putnam PHMR, Krakow, Poland
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH47
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 46 条
  • [1] Immunogenicity of a Live Dengue Vaccine (TAK-003)
    de Silva, Aravinda
    White, Laura
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 163 - 164
  • [2] Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience
    Fernando, LakKumar
    Kastner, Randee
    Wickramasinghe, Pujitha
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Nguyen, Van Hung
    Liu, Mengya
    LeFevre, Inge
    Wallace, Derek
    Folschweiller, Nicolas
    Biswal, Shibadas
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (08):
  • [3] Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)
    Rivera, Luis
    Biswal, Shibadas
    Saez-Llorens, Xavier
    Reynales, Humberto
    Lopez-Medina, Eduardo
    Borja-Tabora, Charissa
    Bravo, Lulu
    Sirivichayakul, Chukiat
    Kosalaraksa, Pope
    Martinez Vargas, Luis
    Yu, Delia
    Watanaveeradej, Veerachai
    Espinoza, Felix
    Dietze, Reynaldo
    Fernando, LakKumar
    Wickramasinghe, Pujitha
    Duarte Moreira Jr, Edson
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Luz, Kleber
    Venancioda Cunha, Rivaldo
    Rauscher, Martina
    Zent, Olaf
    Liu, Mengya
    Hoffman, Elaine
    LeFevre, Inge
    Tricou, Vianney
    Wallace, Derek
    Alera, Maria Theresa
    Borkowski, Astrid
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 107 - 117
  • [4] BRIDGING THE IMMUNOGENICITY OF A TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) FROM CHILDREN AND ADOLESCENTS TO ADULTS
    Halim, C.
    Tricou, V.
    Nordio, F.
    Folschweiller, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S10 - S10
  • [5] COST-EFFECTIVENESS OF THE DENGUE VACCINE TAK-003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    Rungmaitree, S.
    VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
  • [6] Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue
    Saez-Llorens, Xavier
    Biswal, Shibadas
    Borja-Tabora, Charissa
    Fernando, LakKumar
    Liu, Mengya
    Wallace, Derek
    Folschweiller, Nicolas
    Reynales, Humberto
    LeFevre, Inge
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (04): : 722 - 726
  • [7] Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
    Lopez-Medina, Eduardo
    Biswal, Shibadas
    Saez-Llorens, Xavier
    Borja-Tabora, Charissa
    Bravo, Lulu
    Sirivichayakul, Chukiat
    Martinez Vargas, Luis
    Theresa Alera, Maria
    Velasquez, Hector
    Reynales, Humberto
    Rivera, Luis
    Watanaveeradej, Veerachai
    Johana Rodriguez-Arenales, Edith
    Yu, Delia
    Espinoza, Felix
    Dietze, Reynaldo
    Fernando, Lak Kumar
    Wickramasinghe, Pujitha
    Duarte Moreira, Edson
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Luz, Kleber
    Venancio da Cunha, Rivaldo
    Tricou, Vianney
    Rauscher, Martina
    Liu, Mengya
    LeFevre, Inge
    Wallace, Derek
    Kosalaraksa, Pope
    Borkowski, Astrid
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (09): : 1521 - 1532
  • [8] Effectiveness and safety of the tetravalent TAK-003 dengue vaccine: a systematic review
    Bengolea, Agustin
    Scigliano, Clara
    Ramos-Rojas, Jose T.
    Rada, Gabriel
    Catalano, Hugo N.
    Izcovich, Ariel
    MEDICINA-BUENOS AIRES, 2024, 84 (04) : 689 - 707
  • [9] Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate
    Patel, Sanjay S.
    Rauscher, Martina
    Kudela, Maria
    Pang, Hang
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1350 - E1359
  • [10] COST-EFFECTIVENESS ANALYSIS OF THE TAK-003 DENGUE VACCINE INTRODUCTION IN ARGENTINA
    Uruena, A.
    Giglio, N.
    Micone, P., V
    Rapaport, S.
    Towle, P.
    Shih, D.
    Langer, J.
    Carbone, A.
    VALUE IN HEALTH, 2024, 27 (12)
12345